Showing results (101-110 of 380) with videos related to
Sort By:
Pageof 38
American Journal of Hematology|January 25, 2014
Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromesNaval Daver, Kiran Naqvi, Elias Jabbour, et al.American Journal of Hematology|May 12, 2017
Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemiaBrittany Knick Ragon, Naval Daver, Guillermo Garcia-Manero, et al.Clinical Lymphoma, Myeloma & Leukemia|September 8, 2016
Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of MyelodysplasiaKoji Sasaki, Elias Jabbour, Jorge Cortes, et al.The Lancet. Haematology|October 6, 2015
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 studyPreetesh Jain, Hagop Kantarjian, Elias Jabbour, et al.Cancer|April 17, 2018
Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromeRita Assi, Hagop M Kantarjian, Tapan M Kadia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2026
Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE StudyDavid A Sallman, Guillermo Garcia-Manero, Naval Daver, et al.The Lancet. Haematology|December 22, 2015
Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trialsKoji Sasaki, Sara S Strom, Susan O'Brien, et al.Haematologica|June 20, 2015
Ruxolitinib in combination with lenalidomide as therapy for patients with myelofibrosisNaval Daver, Jorge Cortes, Kate Newberry, et al.Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapyNaval Daver, Theresa Liu Dumlao, Farhad Ravandi, et al.Clinical Lymphoma, Myeloma & Leukemia|July 14, 2018
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic SyndromeFevzi Firat Yalniz, Naval Daver, Katayoun Rezvani, et al.Pageof 38